Drug Profile
Glycoside apoptosis inducer/alpha-fetoprotein complex
Alternative Names: Aimpila™Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Constab Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Colorectal cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Colorectal-cancer in Canada (PO, Capsule)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Canada (PO)
- 18 Jun 2007 Phase-I clinical trials in Colorectal cancer in Canada (PO)